Area of research
Radiation · Pulmonary and Respiratory Medicine
Research interest
Research focused on Reproducibility and Proton therapy, with related work in Radiation therapy, Lung cancer, Head and neck cancer. Notable publications include 'Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery', 'Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An...', and 'Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer'.
BRAF<sup><b>V600E</b></sup> Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics
Prospective clinical trial of upright image-guided proton therapy for locally recurrent head and neck and brain malignancies
Complication Rates After Mastectomy and Reconstruction in Breast Cancer Patients Treated with Hypofractionated Radiation Therapy Compared to Conventional Fractionation: A Single Institutional Analysis
Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer
Study of upright patient positioning reproducibility in image-guided proton therapy for head and neck cancers
Commissioning of a novel gantry-less proton therapy system
Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy
Stereotactic radiosurgery for brain metastases arising from gynecological malignancies: A retrospective treatment outcome analysis
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study
Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study
Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations
Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery